- Home
- TRML vs PFIS Comparison
TRML vs PFIS Comparison
Compare TRML & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- PFIS
- Stock Information
- Founded
- TRML 2021
- PFIS 1905
- Country
- TRML United States
- PFIS United States
- Employees
- TRML N/A
- PFIS N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- PFIS Major Banks
- Sector
- TRML Health Care
- PFIS Finance
- Exchange
- TRML Nasdaq
- PFIS Nasdaq
- Market Cap
- TRML 509.8M
- PFIS 517.2M
- IPO Year
- TRML N/A
- PFIS N/A
- Fundamental
- Price
- TRML $12.21
- PFIS $49.25
- Analyst Decision
- TRML Strong Buy
- PFIS Hold
- Analyst Count
- TRML 6
- PFIS 1
- Target Price
- TRML $54.00
- PFIS $47.00
- AVG Volume (30 Days)
- TRML 344.8K
- PFIS 23.9K
- Earning Date
- TRML 03-18-2025
- PFIS 02-06-2025
- Dividend Yield
- TRML N/A
- PFIS 5.01%
- EPS Growth
- TRML N/A
- PFIS N/A
- EPS
- TRML N/A
- PFIS 0.99
- Revenue
- TRML N/A
- PFIS $115,194,000.00
- Revenue This Year
- TRML N/A
- PFIS N/A
- Revenue Next Year
- TRML N/A
- PFIS $6.61
- P/E Ratio
- TRML N/A
- PFIS $49.75
- Revenue Growth
- TRML N/A
- PFIS 14.83
- 52 Week Low
- TRML $12.12
- PFIS $36.26
- 52 Week High
- TRML $48.31
- PFIS $59.70
- Technical
- Relative Strength Index (RSI)
- TRML 25.27
- PFIS 40.41
- Support Level
- TRML $12.13
- PFIS $51.06
- Resistance Level
- TRML $14.58
- PFIS $51.94
- Average True Range (ATR)
- TRML 0.84
- PFIS 1.73
- MACD
- TRML -0.05
- PFIS -0.25
- Stochastic Oscillator
- TRML 1.79
- PFIS 0.00
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.